Source: Eur Respir J, 55 (2) 1902447; 10.1183/13993003.02447-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ulf Nilsson, Lowie E.G.W. Vanfleteren. Troponin as a biomarker for mortality in stable COPD. Eur Respir J, 55 (2) 1902447; 10.1183/13993003.02447-2019

Member's Comments

No comment yet.

Related content which might interest you: Elevated cardiac troponin predicts 11-year mortality in COPD Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study Source: Eur Respir J, 55 (2) 1901314; 10.1183/13993003.01314-2019 Year: 2020 Prognostic value of Cardiac Troponin I in AECOPD and its impact on mortality Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Elevated serum high-sensitivity cardiac troponin I is related to mortality in COPD Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Evaluation of serum troponin level in exacerbation of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005 Cardiac troponin I elevation in the exacerbations of severe COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 High-sensitive troponin T as a new biomarker and an indicator of disease severity in patients with pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Any detectable admission cardiac troponin I level is associated with increased risk of early death following COPD exacerbations Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation Year: 2011 Late Breaking Abstract - High-sensitivity troponin I predicts all-cause mortality in stable COPD in the COSYCONET cohort Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Stable state fibrinogen is additive to MR-proADM as a predictor of mortality in COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 BNP is a predictor of mortality following COPD exacerbations Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation Year: 2011 Copeptin predicts all-cause mortality in stable COPD: An analysis of the COSYCONET study Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Relationships between elevated cardiac troponin levels in COPD exacerbations and subsequent cardiac investigation and management Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Microalbuminuria as a cardiovascular biomarker in patients with COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD Source: Eur Respir J 2014; 43: 951-953 Year: 2014 Increased prevalence of elevated high-sensitivity cardiac troponin T among patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Mortality risk prediction in COPD by a prognostic biomarker panel Source: Eur Respir J 2014; 44: 1557-1570 Year: 2014 Cardiac biomarkers and outcomes of COPD exacerbations Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019